Ticagrelor 90 mg/1

Ticagrelor 90 mg tablets are an antiplatelet medication used to prevent blood clots. This film-coated tablet is manufactured by Mylan Pharmaceuticals Inc. in the USA.

Ticagrelor is primarily used to reduce the risk of blood clots in individuals with certain heart conditions. It is often prescribed for patients who have experienced a heart attack or have acute coronary syndrome. The medication works by inhibiting platelet aggregation, which helps to maintain blood flow and prevent clotting. Ticagrelor 90 mg tablets are taken orally and are designed to provide consistent therapeutic effects.

Common effects of Ticagrelor may include shortness of breath, bleeding, and bruising. Some users may experience dizziness or fatigue. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Ticagrelor should be handled with care, especially by individuals with a history of bleeding disorders or those who are prone to bruising. It is important to follow the prescribed dosage and administration instructions. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Ticagrelor may interact with other medications, including blood thinners, NSAIDs, and certain antidepressants. It is also important to avoid alcohol while taking Ticagrelor, as it can increase the risk of bleeding. Always consult a healthcare provider before starting or stopping any medication.